Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by Summit Global Investments

Summit Global Investments lessened its stake in Addus HomeCare Co. (NASDAQ:ADUSFree Report) by 17.8% in the 4th quarter, HoldingsChannel.com reports. The fund owned 12,162 shares of the company’s stock after selling 2,626 shares during the period. Summit Global Investments’ holdings in Addus HomeCare were worth $1,129,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in shares of Addus HomeCare by 4.9% in the 3rd quarter. Vanguard Group Inc. now owns 1,218,564 shares of the company’s stock valued at $103,809,000 after purchasing an additional 57,040 shares during the last quarter. Wellington Management Group LLP lifted its stake in Addus HomeCare by 2.5% in the third quarter. Wellington Management Group LLP now owns 788,887 shares of the company’s stock valued at $67,205,000 after buying an additional 18,872 shares during the last quarter. Summit Creek Advisors LLC lifted its stake in Addus HomeCare by 14.5% in the third quarter. Summit Creek Advisors LLC now owns 288,158 shares of the company’s stock valued at $24,548,000 after buying an additional 36,578 shares during the last quarter. TimesSquare Capital Management LLC boosted its holdings in shares of Addus HomeCare by 55.0% in the third quarter. TimesSquare Capital Management LLC now owns 233,758 shares of the company’s stock valued at $19,914,000 after acquiring an additional 82,920 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its position in shares of Addus HomeCare by 3.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 167,243 shares of the company’s stock worth $14,247,000 after acquiring an additional 5,225 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Stock Performance

NASDAQ:ADUS traded down $0.21 during mid-day trading on Friday, reaching $98.20. The stock had a trading volume of 117,674 shares, compared to its average volume of 155,735. Addus HomeCare Co. has a twelve month low of $77.30 and a twelve month high of $104.61. The business has a 50 day simple moving average of $98.27 and a 200 day simple moving average of $92.19. The firm has a market capitalization of $1.61 billion, a price-to-earnings ratio of 25.57, a PEG ratio of 1.94 and a beta of 0.96. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last posted its quarterly earnings results on Monday, February 26th. The company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.04 by $0.17. Addus HomeCare had a return on equity of 9.70% and a net margin of 5.91%. The business had revenue of $276.35 million during the quarter, compared to analysts’ expectations of $274.02 million. On average, analysts expect that Addus HomeCare Co. will post 4.38 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

ADUS has been the subject of a number of recent research reports. Royal Bank of Canada reiterated an “outperform” rating and set a $102.00 price target on shares of Addus HomeCare in a research note on Thursday, February 29th. Barclays downgraded shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 target price for the company. in a research note on Tuesday, April 23rd. William Blair restated an “outperform” rating on shares of Addus HomeCare in a research report on Monday, February 5th. Finally, Oppenheimer reaffirmed an “outperform” rating and set a $118.00 price objective on shares of Addus HomeCare in a research note on Tuesday, March 26th. One research analyst has rated the stock with a sell rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $103.00.

View Our Latest Stock Analysis on Addus HomeCare

Addus HomeCare Company Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Read More

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.